Luca Zambelli
Overview
Explore the profile of Luca Zambelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zambelli L, Gigliotti A, Bianchessi C, Liguori S, Defendi S
Tumori
. 2025 Jan;
:3008916251316175.
PMID: 39885641
Background: Global migration has led to an increasing number of migrant patients receiving cancer diagnoses in foreign countries. These individuals often experience worse outcomes due to advanced disease at diagnosis...
2.
Ghelardi F, Fuca G, Cavalli C, Shitara K, Cohen R, Ambrosini M, et al.
Dig Liver Dis
. 2024 May;
57(1):23-29.
PMID: 38772790
Background: Microsatellite instability high (MSI-H) and/or mismatch repair deficient (dMMR) status is the strongest predictive factor for immune checkpoint inhibitors (ICIs) benefit in patients with metastatic gastroesophageal cancer (mGC). Primary...
3.
Massa G, Zambelli L, Zecca E, Shkodra M, Tine G, Caraceni A
Oncologist
. 2024 Mar;
29(6):e728-e740.
PMID: 38518107
Background: In male patients with cancer treated with antineoplastic drug, hypogonadism is a neglected cause of diminished quality of life. This condition may be cancer related as well as toxicity...
4.
Provenzano L, Lobefaro R, Ligorio F, Zattarin E, Zambelli L, Sposetti C, et al.
Ther Adv Med Oncol
. 2023 Apr;
15:17588359231165978.
PMID: 37063779
Background: Advanced triple-negative breast cancer (aTNBC) has a poor prognosis; thus, there is a need to identify novel biomarkers to guide future research and improve clinical outcomes. Objectives: We tested...
5.
Randon G, Maddalena G, Germani M, Pircher C, Manca P, Bergamo F, et al.
JCO Precis Oncol
. 2022 May;
6:e2200037.
PMID: 35544729
Purpose: Several uncommon genomic alterations beyond and BRAFV600E mutations drive primary resistance to anti-epidermal growth factor receptors (EGFRs) in metastatic colorectal cancer (mCRC). Our PRESSING panel (including exon 20// mutations,...
6.
Ligorio F, Zambelli L, Fuca G, Lobefaro R, Santamaria M, Zattarin E, et al.
Ther Adv Med Oncol
. 2022 Mar;
14:17588359221079123.
PMID: 35281350
Human Epidermal growth factor Receptor 2 (HER2) overexpression or gene amplification defines a subset of breast cancers (BCs) characterized by higher biological and clinical aggressiveness. The introduction of anti-HER2 drugs...
7.
Zanella C, Leone A, Zambelli L, Bottiglieri A, Canziani L, Brambilla M, et al.
Tumori
. 2022 Mar;
108(6):NP11-NP14.
PMID: 35260015
Paraneoplastic syndromes occur in about 0.1% of patients affected by neoplastic diseases. In some types of tumors, such as Small Cell Lung Cancer (SCLC), Thymoma, and particular forms of Plasmacytoma,...
8.
Zambelli L, Pegreffi F
Int J Risk Saf Med
. 2022 Feb;
33(2):133-144.
PMID: 35147565
Background: The research is placed in the context of interdisciplinary medical-legal studies on the importance of promoting physical activity as a public health tool. Objective: The aim was to highlight...
9.
Ligorio F, Zambelli L, Bottiglieri A, Castagnoli L, Zattarin E, Lobefaro R, et al.
Ther Adv Med Oncol
. 2021 May;
13:17588359211006960.
PMID: 33948122
Background: High body mass index (BMI) has been associated with worse clinical outcomes in patients with early-stage breast cancer (BC), and its negative effects could be mediated by hyperglycemia/diabetes. However,...
10.
Ligorio F, Fuca G, Zattarin E, Lobefaro R, Zambelli L, Leporati R, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33921727
Different peripheral blood parameters have emerged as prognostic biomarkers in breast cancer (BC), but their predictive role in Human Epidermal growth factor Receptor 2 positive (HER2+) advanced BC (aBC) patients...